HETERO LABS LTD III FDA Approval ANDA 090061

ANDA 090061

HETERO LABS LTD III

FDA Drug Application

Application #090061

Application Sponsors

ANDA 090061HETERO LABS LTD III

Marketing Status

Prescription001

Application Products

001TABLET;ORAL5MG0FINASTERIDEFINASTERIDE

FDA Submissions

ORIG1AP2010-06-07
LABELING; LabelingSUPPL3AP2012-02-14
LABELING; LabelingSUPPL5AP2013-02-22STANDARD
LABELING; LabelingSUPPL6AP2013-04-26STANDARD
LABELING; LabelingSUPPL8AP2015-04-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2015-04-06UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2015-03-19UNKNOWN
LABELING; LabelingSUPPL17AP2022-03-11STANDARD
LABELING; LabelingSUPPL18AP2022-03-11STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null15
SUPPL5Null15
SUPPL6Null15
SUPPL8Null15
SUPPL9Null7
SUPPL10Null7
SUPPL17Null15
SUPPL18Null15

TE Codes

001PrescriptionAB

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90061
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"FINASTERIDE","activeIngredients":"FINASTERIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"FINASTERIDE","submission":"FINASTERIDE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.